KIBLOK Trademark

Trademark Overview

On Wednesday, November 13, 2013, a trademark application was filed for KIBLOK with the United States Patent and Trademark Office. The USPTO has given the KIBLOK trademark a serial number of 86117943. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 3, 2017. This trademark is owned by Glaxo Group Limited. The KIBLOK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
kiblok

General Information

Serial Number86117943
Word MarkKIBLOK
Filing DateWednesday, November 13, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 3, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 1, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "KIBLOK" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 26, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, July 3, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 3, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 8, 2016EXTENSION 5 GRANTED
Tuesday, October 18, 2016EXTENSION 5 FILED
Tuesday, October 18, 2016TEAS EXTENSION RECEIVED
Tuesday, May 17, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, May 14, 2016EXTENSION 4 GRANTED
Monday, April 18, 2016EXTENSION 4 FILED
Monday, April 18, 2016TEAS EXTENSION RECEIVED
Thursday, October 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 28, 2015EXTENSION 3 GRANTED
Monday, October 19, 2015EXTENSION 3 FILED
Wednesday, October 28, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 19, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, May 30, 2015EXTENSION 2 GRANTED
Thursday, April 30, 2015EXTENSION 2 FILED
Saturday, May 30, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 30, 2015TEAS EXTENSION RECEIVED
Saturday, November 1, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 30, 2014EXTENSION 1 GRANTED
Thursday, October 30, 2014EXTENSION 1 FILED
Thursday, October 30, 2014TEAS EXTENSION RECEIVED
Tuesday, May 27, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 1, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 1, 2014PUBLISHED FOR OPPOSITION
Wednesday, March 12, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 18, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 11, 2014ASSIGNED TO EXAMINER
Tuesday, November 26, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 16, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

kiblok pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological